Abstract
There is a lack of evidence-based guidance for the prevention and management of thrombosis in children and young people treated for acute lymphoblastic leukemia. To determine current UK practice, a survey was sent to 28 centers participating in the Medical Research Council UKALL 2011 trial. Marked variation in practice was noted. In total, 43% of centers defer central venous access device insertion until end of induction for treatment of low-risk disease. Central venous access devices are removed at the end of intensive blocks in 38% and end of treatment in 42%. Duration of anticoagulation for line-associated thrombosis is 6 weeks in 43% and 3 months in 33% and for cerebral sinovenous thrombosis is 3 months in 71% and 6 months in 24%. Platelet transfusion to maintain platelet count >50×10/L, in preference to interrupting therapeutic anticoagulation, is used by 50% for line-associated thrombosis and 73% for cerebral sinovenous thrombosis. Conformity of practice was seen in some areas. In total, 70% treat thrombosis with twice-daily low-molecular weight heparin and 86% monitor antifactor Xa activity levels. In total, 91% reexpose individuals to asparaginase following a thrombotic event. Given this variation in practice, in the ab...Continue Reading
References
Nov 24, 1999·Lancet·C VasilakisM del Mar Melero-Montes
Jan 29, 2000·European Journal of Pediatrics·C WermesK W Sykora
Feb 27, 2001·Blood·L B SilvermanS E Sallan
Aug 11, 2001·The New England Journal of Medicine·G deVeberUNKNOWN Canadian Pediatric Ischemic Stroke Study Group
Apr 23, 2003·Thrombosis Research·Patricia MassicotteUNKNOWN PROTEKT Study Group
Jul 31, 2003·Thrombosis and Haemostasis·Lesley MitchellDavid Mikulis
Apr 30, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas W McLeanAllen R Chauvenet
Aug 16, 2005·Blood·Marilyn J Manco-Johnson
Jun 29, 2006·Blood·Vanesa CarusoMaria Benedetta Donati
Jul 5, 2007·British Journal of Haematology·Jeanette H Payne, Ajay J Vora
Jan 16, 2008·Journal of Thrombosis and Haemostasis : JTH·S KuhleL G Mitchell
Nov 28, 2009·Contemporary Clinical Trials·Neil A GoldenbergWilliam R Hiatt
Mar 6, 2010·British Journal of Haematology·Amrana QureshiNick Goulden
Jun 10, 2010·British Journal of Haematology·Jeanette H Payne
Jun 29, 2010·Pediatric Blood & Cancer·Mette Møller HandrupHenrik Schrøder
Jan 8, 2011·British Journal of Haematology·Rachael F GraceLewis B Silverman
May 21, 2011·British Journal of Haematology·Elizabeth ChalmersUNKNOWN British Committee for Standards in Haematology
Feb 15, 2012·Chest·Paul MonagleSara K Vesely
Nov 28, 2012·Pediatric Surgery International·Alan D WhiteRoly Squire
Dec 12, 2012·Journal of Thrombosis and Haemostasis : JTH·D FargeH R Büller
Dec 12, 2012·Journal of Thrombosis and Haemostasis : JTH·P DebourdeauH Bounameaux
May 24, 2013·Lancet·Vineet ChopraScott A Flanders
Jul 3, 2013·Journal of Thrombosis and Haemostasis : JTH·M CarrierUNKNOWN Subcommittee on Haemostasis and Malignancy for the SSC of the ISTH
Jul 23, 2013·Pediatric Blood & Cancer·David Spencer MangumMark Fluchel
Oct 8, 2014·Archives of Disease in Childhood·R N IchordUNKNOWN International Paediatric Stroke Study Group
Citations
Apr 18, 2018·Blood·Cecilie Utke RankKjeld Schmiegelow
Feb 1, 2018·British Journal of Haematology·Keith R SibsonUNKNOWN British Society for Haematology
Sep 29, 2019·International Journal of Hematology·Shinya OsoneSouichi Adachi